Regardless of whether you prescribe GLP-1 medications, assess patients use of these medications and provide relevant contraceptive counseling as appropriate
Unlike Wegovy and Zepbound, which must pass through stringent testing and meet established safety standards, compounded drugs are essentially unregulated
Common symptoms include nausea, constipation, diarrhea, bloating, and appetite suppression
Recent clinical research has revealed that GLP-1 receptor agonists have what scientists call a "hypodipsic effect"essentially, they suppress your natural desire to drink water
Clinical Pharmacology of GLP-1 RAs The approval of the first GLP-1 RA, exenatide, by the FDA in 2005 marked a significant advancement in treating diabetes and obesity